These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20518843)

  • 21. No association of the codon 55 methionine to valine polymorphism in the SUMO4 gene with Graves' disease.
    Jennings CE; Owen CJ; Wilson V; Pearce SH
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):362-5. PubMed ID: 15730420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of MCP-1-2518A/G polymorphism with susceptibility to autoimmune diseases: a meta-analysis.
    Chen S; Deng C; Hu C; Li J; Wen X; Wu Z; Li Y; Zhang F; Li Y
    Clin Rheumatol; 2016 May; 35(5):1169-79. PubMed ID: 26318885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of association of IL-10 gene polymorphisms with prostate cancer: evidence from 11,581 subjects.
    Zou YF; Wang F; Feng XL; Tian YH; Tao JH; Pan FM; Huang F
    Eur J Cancer; 2011 May; 47(7):1072-9. PubMed ID: 21211963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SUMO4 163 G>A variation is associated with kidney disease in Indian subjects with type 2 diabetes.
    Sinha N; Yadav AK; Kumar V; Dutta P; Bhansali A; Jha V
    Mol Biol Rep; 2016 May; 43(5):345-8. PubMed ID: 27055882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between lncRNA H19 polymorphisms and cancer susceptibility based on a meta-analysis from 25 studies.
    Liu C; Chen L; You Z; Wu Y; Wang C; Zhang G; Xu B; Chen M
    Gene; 2020 Mar; 729():144317. PubMed ID: 31884107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No association of the SUMO4 polymorphism M55V variant in type 2 diabetes in Iranian subjects.
    Fallah S; Jafarzadeh M; Hedayati M
    Diabetes Res Clin Pract; 2010 Nov; 90(2):191-5. PubMed ID: 20728233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analyses of multiple single-nucleotide polymorphisms in the SUMO4/IDDM5 region in affected sib-pair families with type I diabetes.
    Podolsky R; Prasad Linga-Reddy MV; She JX;
    Genes Immun; 2009 Dec; 10 Suppl 1(Suppl 1):S16-20. PubMed ID: 19956095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of the interleukin-10 gene polymorphism (-1082A/G) with systemic lupus erythematosus: a meta-analysis.
    Zhou M; Ding L; Peng H; Wang B; Huang F; Xu WD; Li JH; Ye XR; Pan HF; Ye DQ
    Lupus; 2013 Feb; 22(2):128-35. PubMed ID: 23192326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between interleukin-10 -1082A/G polymorphism and risk of ischemic stroke: a meta-analysis.
    Jin J; Li W; Peng L; Chen J; Li R; Wu P; Tan S
    PLoS One; 2014; 9(4):e94631. PubMed ID: 24732312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes.
    Smyth DJ; Howson JM; Lowe CE; Walker NM; Lam AC; Nutland S; Hutchings J; Tuomilehto-Wolf E; Tuomilehto J; Guja C; Ionescu-Tîrgoviste C; Undlien DE; Rønningen KS; Savage D; Dunger DB; Twells RC; McArdle WL; Strachan DP; Todd JA
    Nat Genet; 2005 Feb; 37(2):110-1; author reply 112-3. PubMed ID: 15678134
    [No Abstract]   [Full Text] [Related]  

  • 31. Genetics of type 1 diabetes: similarities and differences between Asian and Caucasian populations.
    Ikegami H; Fujisawa T; Kawabata Y; Noso S; Ogihara T
    Ann N Y Acad Sci; 2006 Oct; 1079():51-9. PubMed ID: 17130532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of association between Fas rs180082 polymorphism and risk of cervical cancer: an update by meta-analysis.
    Chen X; Mo W; Peng Q; Su X
    BMC Med Genet; 2013 Jul; 14():71. PubMed ID: 23865866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of SUMO4 Met55Val variation with increased insulin resistance in newly diagnosed type 2 diabetes in a Chinese population.
    Ji Z; Dai Z; Huang Y; Martins HA; Xu Y
    J Huazhong Univ Sci Technolog Med Sci; 2011 Jun; 31(3):306-311. PubMed ID: 21671169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes.
    Park Y; Park S; Kang J; Yang S; Kim D
    Nat Genet; 2005 Feb; 37(2):112; author reply 112-3. PubMed ID: 15678137
    [No Abstract]   [Full Text] [Related]  

  • 35. Association of small ubiquitin-like modifier 4 (SUMO4) variant, located in IDDM5 locus, with type 2 diabetes in the Japanese population.
    Noso S; Fujisawa T; Kawabata Y; Asano K; Hiromine Y; Fukai A; Ogihara T; Ikegami H
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2358-62. PubMed ID: 17374705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
    Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z
    PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between the pre-mir-218 polymorphism and cancer risk in the Chinese population: a meta-analysis.
    Gao Y; Liu Y; Liu GL; Ran LK; Zeng F; Wu JY; Song FZ
    Asian Pac J Cancer Prev; 2014; 15(6):2517-22. PubMed ID: 24761857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of TNF-alpha promoter - 238A/G polymorphism and SLE susceptibility.
    Zou YF; Feng XL; Pan FM; Su H; Tao JH; Ye DQ
    Autoimmunity; 2010 Jun; 43(4):264-74. PubMed ID: 20166876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of CTLA-4 A49G polymorphism on rheumatoid arthritis risk: a meta-analysis.
    Li G; Shi F; Liu J; Li Y
    Diagn Pathol; 2014 Aug; 9():157. PubMed ID: 25128482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic Polymorphism of DNA Methyltransferase 3A rs1550117 A>G and Risk of Cancer: A Meta-analysis.
    Zhang W; Xu Y; Ma G; Qi W; Gu H; Jiang P
    J Invest Surg; 2015; 28(6):346-53. PubMed ID: 26203494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.